Your browser doesn't support javascript.
loading
Correction: Efficacy and Safety of AbobotulinumtoxinA for the Treatment of Glabellar Lines in Chinese Patients: A Pivotal, Phase 3, Randomized, Double-Blind and Open-Label Phase Study.
Wu, Yan; Fang, Fang; Lai, Wei; Li, Chengxin; Li, Li; Liu, Quanzhong; Lu, Jianyun; Pang, Xiaowen; Sun, Jiaming; Shi, Xiaofeng; Picaut, Philippe; Prygova, Inna; Andriopoulos, Bill; Sun, Qiuning.
Afiliación
  • Wu Y; Peking University First Hospital, No. 8 Xishiku Street, Xicheng, Beijing, 100034, China. 3437477565@qq.com.
  • Fang F; Institute of Dermatology, Chinese Academy of Medical Sciences, Nanjing, China.
  • Lai W; Department of Dermatology, The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China.
  • Li C; General Hospital of People's Liberation Army (301 Hospital), Beijing, China.
  • Li L; West China Hospital, Sichuan University, Chengdu, China.
  • Liu Q; Tianjin Medical University General Hospital, Tianjin, China.
  • Lu J; Third Xiangya Hospital of Central South University, Changsha, China.
  • Pang X; PLA Air Force General Hospital, Beijing, China.
  • Sun J; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Shi X; Ipsen, Shanghai, China.
  • Picaut P; Ipsen, Cambridge, MA, USA.
  • Prygova I; Ipsen, Boulogne-Billancourt, France.
  • Andriopoulos B; Galderma, Uppsala, Sweden.
  • Sun Q; Peking Union Medical College Hospital, Beijing, China.
Aesthetic Plast Surg ; 47(3): 1243, 2023 Jun.
Article en En | MEDLINE | ID: mdl-36951993

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Año: 2023 Tipo del documento: Article